These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17292047)

  • 1. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.
    Heydemann A; McNally EM
    Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoglycans in muscular dystrophy.
    Hack AA; Groh ME; McNally EM
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.
    Lapidos KA; Kakkar R; McNally EM
    Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of sarcoglycan, neuronal nitric oxide synthase, beta-dystroglycan, and dystrophin molecules in normal skeletal myofiber: triple immunogold labeling electron microscopy.
    Wakayama Y; Inoue M; Kojima H; Murahashi M; Shibuya S; Oniki H
    Microsc Res Tech; 2001 Nov; 55(3):154-63. PubMed ID: 11747090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.
    Hack AA; Lam MY; Cordier L; Shoturma DI; Ly CT; Hadhazy MA; Hadhazy MR; Sweeney HL; McNally EM
    J Cell Sci; 2000 Jul; 113 ( Pt 14)():2535-44. PubMed ID: 10862711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants.
    Allikian MJ; Bhabha G; Dospoy P; Heydemann A; Ryder P; Earley JU; Wolf MJ; Rockman HA; McNally EM
    Hum Mol Genet; 2007 Dec; 16(23):2933-43. PubMed ID: 17855453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing and assembly of the dystrophin glycoprotein complex.
    Allikian MJ; McNally EM
    Traffic; 2007 Mar; 8(3):177-83. PubMed ID: 17274800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.
    Chen J; Shi W; Zhang Y; Sokol R; Cai H; Lun M; Moore BF; Farber MJ; Stepanchick JS; Bönnemann CG; Chan YM
    Exp Cell Res; 2006 May; 312(9):1610-25. PubMed ID: 16524571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional nitric oxide synthase mislocalization in cardiomyopathy.
    Heydemann A; Huber JM; Kakkar R; Wheeler MT; McNally EM
    J Mol Cell Cardiol; 2004 Feb; 36(2):213-23. PubMed ID: 14871549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoglycan subcomplex in normal human smooth muscle: an immunohistochemical and molecular study.
    Anastasi G; Cutroneo G; Sidoti A; Santoro G; D'Angelo R; Rizzo G; Rinaldi C; Giacobbe O; Bramanti P; Navarra G; Amato A; Favaloro A
    Int J Mol Med; 2005 Sep; 16(3):367-74. PubMed ID: 16077941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoglycan subcomplex in normal and pathological human muscle fibers.
    Anastasi G; Cutroneo G; Rizzo G; Favaloro A
    Eur J Histochem; 2007; 51 Suppl 1():29-33. PubMed ID: 17703591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle.
    Allikian MJ; Hack AA; Mewborn S; Mayer U; McNally EM
    J Cell Sci; 2004 Aug; 117(Pt 17):3821-30. PubMed ID: 15252120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of the striated muscle dystrophin-glycoprotein complex.
    Ervasti JM; Sonnemann KJ
    Int Rev Cytol; 2008; 265():191-225. PubMed ID: 18275889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect.
    Vatta M; Sinagra G; Brunelli L; Faulkner G
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):149-56. PubMed ID: 19194174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
    Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
    Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?
    Towbin JA; Bowles NE
    J Clin Invest; 2001 Jan; 107(2):153-4. PubMed ID: 11160128
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel γ-sarcoglycan-mutation affects cardiac function and N-terminal dystrophin expression.
    Schröder NW; Grieben U; Prokop S; Dekomien G; Epplen JT; Heppner FL; Goebel HH; Stenzel W
    Muscle Nerve; 2014 Jan; 49(1):144-5. PubMed ID: 23929688
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.
    Cohn RD; Durbeej M; Moore SA; Coral-Vazquez R; Prouty S; Campbell KP
    J Clin Invest; 2001 Jan; 107(2):R1-7. PubMed ID: 11160141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy.
    Batchelor CL; Winder SJ
    Trends Cell Biol; 2006 Apr; 16(4):198-205. PubMed ID: 16515861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.